Go to top
R&D

R&D Center

Will become a leading company in the active pharmaceutical ingredient (API) industry.

R&D

For the world’s highest quality generic ingredients

Since establishment in 2002, Hanseochem R&D Center have developed original technology and expanded the research area through enhancing research capability by intensive R&D investment, securing excellent research staff and collaboration with the nation’s leading universities. Also we entered not only into domestic pharmaceutical market but also Japanese pharmaceutical market by developing technology of the highest quality pharmaceutical ingredients that correspond to KP, USP, EP and JP.

  • Synthetic research

    • Development of synthetic methods for active pharmaceutical ingredients (APIs) and intermediates
    • Development of new drugs by improving raw pharmaceutical ingredients through the introduction of new salts
    • Development of functional raw materials derived from natural products
    • Development of a customized raw pharmaceutical manufacturing method for each client
  • Analytical research

    • CTD material preparation
    • Establishment of standards and test methods for raw pharmaceutical ingredients (API)
    • Method development and validation
    • Impurity profile research and standard form establishment
    • Genotoxicity study of API flexible substances using quantitative structure–activity relationship (QSAR)
  • Technical sales

    • Providing differentiated APIs and technical services to domestic and international clients based on our core original technologies.
  • CDMO

    • Providing domestic and international CDMO business services
    • Establishing an optimized mass production process and producing high-quality pharmaceuticals
    • Preparation of CTD data for GMP production and license registration
Hanseochem Co., Ltd.
  • Address

    41 Poseunggongdan-ro, Poseung-eup, Pyeongtaek-si, Kyeonggi-do

  • TEL

    031-682-8655

  • FAX

    031-682-8656

  • E-Mail

    hanseochem@hanseochem.co.kr